A preliminary characterization of the immunomodulatory activity of isoprinosine in mice was conducted in both normal and tumor-bearing mice. Under the experimental conditions employed, isoprinosine given i.p. and orally was found to possess some immunomodulatory capacity in various model systems. The compound appeared to preferentially influence T- but not B-cell responses; it did not apparently influence the functional capacity of macrophages, K cells, and NK cells.
|Number of pages||5|
|Journal||Cancer Treatment Reports|
|Publication status||Published - 1978|
ASJC Scopus subject areas
- Cancer Research